to common stockholders $0.71 - 0.74
Minority interest in operating partnership $0.03
Real estate depreciation and amortization $1.10
Projected FFO per diluted share $1.84 - $1.87
The company's initial 2009 guidance for net income per diluted share
and FFO per diluted share is set forth and reconciled below.
(Low - High)
Projected net income per diluted share available
to common stockholders $0.54 - 0.74
Minority interest $0.02
Real estate depreciation and amortization $1.04
Projected FFO per diluted share $1.60 - $1.80
Consistent with the 2008 guidance, the company's 2009 guidance does not include the impact of future acquisition activities. In addition, the company's 2009 guidance includes the estimated impact of the change in accounting for its exchangeable senior notes, the company's October 2008 common stock offering and higher anticipated financing costs.
The foregoing estimates are forward-looking and reflect management's view of current and future market conditions, including certain assumptions with respect to leasing activity, rental rates, occupancy levels, financing transactions, interest rates, and the amount and timing of development and redevelopment activities. The company's actual results may differ materially from these estimates.
Supplemental operating and financial data are available in the Investor
Relations section of the company's web site at http://www.biomedreal
|SOURCE BioMed Realty Trust, Inc.|
Copyright©2008 PR Newswire.
All rights reserved